From: Fertility News From Medical News Today
Ferring Pharmaceuticals presented an interim study analysis
indicating that MENOPUR® (menotropins for injection,
USP) is effective in in vitro fertilization (IVF) cycles using a
gonadotropin-releasing hormone (GnRH) antagonist. The results were
presented in a poster at the 65th Annual Meeting of the American
Society for Reproductive Medicine (ASRM) in Atlanta, October 17-21,
2009. MENOPUR® vs.
Respond to this topic on your own blog
Click and press Ctrl+C to copy and paste this discussion on your blog or site
Related Articles
New Data Supports Significant Economic And Clinical Value Of MENOPUR(R) In IVF
New data from an economic analysis presented today at this year's
European Society of Human Reproduction and Embryology (ESHRE)
congress showed that, within the parameters of the simulation model
used, the in vitro fertilisation (IVF) treatment MENOPUR
(highly-purified human menopausal gonatropin or HP-hMG) offered
considerable cost-savings over recombinant follicle stimulating
hormone (rFSH).
Fewer Multiple Births With IVF Insurance Coverage
The proportion of in vitro fertilization (IVF) multiple births was
lower in the eight states that provide insurance coverage for
couples seeking IVF treatment, primarily due to fewer embryos
transferred per cycle, Yale School of Medicine researchers report
in an abstract presented at the American Society for Reproductive
Medicine meeting in Atlanta, Georgia, October 17-21. IVF remains an
expensive treatment option for those with infertility, and many
cannot afford it.
New Data Supports Significant Economic and Clinical Value of Menopur in IVF
New data from an economic analysis presented today at this year's
European Society of Human Reproduction and Embryology congress
showed that, within the parameters of the simulation model used,
the in vitro fertilisation treatment MENOPUR offered considerable
cost-savings over recombinant follicle stimulating hormone .[1] The
cost-effectiveness of ...
Stress Puts Double Whammy On Reproductive System, Fertility
University of California, Berkeley, researchers have found what
they think is a critical and, until now, missing piece of the
puzzle about how stress causes sexual dysfunction and infertility.
Scientists know that stress boosts levels of stress hormones -
glucocorticoids such as cortisol - that inhibit the bodys main sex
hormone, gonadotropin releasing hormone GnRH, and subsequently
suppresses sperm count, ovulation and sexual activity.
Stress Puts Double Whammy On Reproductive System, Fertility
University of California, Berkeley, researchers have found what
they think is a critical and, until now, missing piece of the
puzzle about how stress causes sexual dysfunction and infertility.
Scientists know that stress boosts levels of stress hormones -
glucocorticoids such as cortisol - that inhibit the bodys main sex
hormone, gonadotropin releasing hormone GnRH, and subsequently
suppresses sperm count, ovulation and sexual activity.